0001493152-23-000026.txt : 20230103 0001493152-23-000026.hdr.sgml : 20230103 20230103062009 ACCESSION NUMBER: 0001493152-23-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221229 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dritschilo Anatoly CENTRAL INDEX KEY: 0001945126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41488 FILM NUMBER: 23500104 MAIL ADDRESS: STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC. STREET 2: ONE RESEARCH COURT, SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001757499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2404034212 MAIL ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 ownership.xml X0306 4 2022-12-29 0 0001757499 Shuttle Pharmaceuticals Holdings, Inc. SHPH 0001945126 Dritschilo Anatoly C/O SHUTTLE PHARMACEUTICALS HOLDINGS ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850 1 1 1 0 CEO and Chairman COMMON STOCK 2022-12-29 4 S 0 8372 1.605 D 1085200 D COMMON STOCK 3204407 I By spouse Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 22,748 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 1,085,200 shares of common stock held directly by the Reporting Person. Consists of 3,204,407 shares of common stock held by the Reporting Person's spouse, over which the Reporting Person disclaims any beneficial ownership or control. The inclusion in this report of the 3,204,407 shares held by the Reporting Person's spouse shall in no way be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Anatoly Dritschilo 2023-01-03